ABN Newswire

Sunridge International (PINK:SNDZ) Sale of Assets to Westhouse Medical

newsroom@abnnewswire.net — Thu, 16 May 2013 13:07:49 GMT

Sunridge International (PINK:SNDZ), announced today that it will not be moving forward with the sale of its assets to Westhouse Medical of London, England due to Westhouse's failure to make certain payments as required by the asset purchase agreement entered into between the parties.

Sunridge intends to invoke the arbitration provision of the asset purchase agreement to address issues raised as a result of Westhouse's failure to make the required payments.

Jeff Smith, Sunridge International
T:  +1-480-837-6165
e-mail: info@sunridgeint.com

Westhouse Medical Services Plc (FRA:5WM) Targeted Acquisition Part of Company's Continuing International Corporate Expansion

newsroom@abnnewswire.net — Thu, 13 Dec 2012 09:31:55 GMT

Healthcare specialist Westhouse Medical Services Plc (FRA:5WM) is pleased to announce that following its announcement of its acquisition of 52% of the issued share capital of Quy Biosciences Limited (Quy) through private placement in November 2012, Westhouse has now acquired a further 47.5% of the issued share capital of Quy. The outstanding 0.5% of Quy issued share capital will be transfer to Westhouse under drag and tag rules, giving Westhouse 100% of the Quy issued share capital and making it a wholly owned subsidiary.

The acquisition values Quy at GBP3.25m.

Quy develop clinical products and services in the regenerative medicine field. Quy are conducting and collaborating on research into wound healing technologies which will lead to further pioneering products in the regenerative medicine field through stem cell therapy and allow the company to further develop the technology for human patients.

Westhouse is also currently developing a number of medical devices, including BreastCheck - a new low-cost, non-invasive breast cancer screening product which can act as a precursor to mammogram scanning. BreastCheck is due for launch in 2013.

Westhouse recently acquired from US-listed Sunridge International via. Sunridge's subsidiary, Ophthalmic International Inc, a glaucoma procedure called PNT, which could revolutionise the way glaucoma is treated globally.

WESTHOUSE MEDICAL SERVICES PLC
SYMBOL: 5WM
WKN: A1JKH7
ISIN: GB00B6YWDK49
SEDOL: B6YWDK4

~ends~

For press information, contact: 
Global Press and Public Relations: 

Gabriel Luca 
Wedgewood Communications 
60 Madison Avenue 
Suite 1212 
New York 
NY 10010 USA 
Tel: +1 646 592 7559
westhouse@wwprnews.com

Westhouse Medical Services Plc (FRA:5WM) Announces Appointment of Mr Nigel Kershaw as New Non-Executive Director

newsroom@abnnewswire.net — Wed, 12 Dec 2012 09:37:17 GMT

Healthcare specialist Westhouse Medical Services Plc (FRA:5WM) today announces the appointment of Mr Nigel Kershaw OBE as Non-Executive Director. Nigel is Group Chairman of The Big Issue having previously been its Chief Executive. He is also the CEO of Big Issue Invest, the UK's leading innovative provider of investment to social enterprises seeking to deliver both financial and social dividends.

He has extensive experience of building and restructuring operational businesses and launching successful, innovative new ventures as well as attracting financial investment and delivering both a financial and social return on investment.

Previous to joining The Big Issue in 1994, Nigel founded three employee owned printing and publishing companies and worked as a project manager, works manager, systems analyst, printer and trade union official. He trained as a four colour lithographic printer and gained his Diploma at the London College of Communication, now the University of the Arts, where he was also Chairman of the Board of Governors.

Nigel is a member of both the Big Society Capital and the British Venture Capital Association's Responsible Investment Advisory Boards. In 2008, Nigel was the winner of the Institute of Director's Good Enterprise Award.

He is a Fellow of the RSA and received an OBE in the 2010 New Year's Honours List for his services to social enterprise.

Westhouse is currently developing a number of medical devices, including BreastCheck - a new low-cost, non-invasive breast cancer screening product which can act as a precursor to mammogram scanning. BreastCheck is due for launch in 2013.

Westhouse recently acquired from US-listed Sunridge International via. Sunridge's subsidiary, Ophthalmic International Inc, a glaucoma procedure called PNT, which could revolutionise the way glaucoma is treated globally.

WESTHOUSE MEDICAL SERVICES PLC
SYMBOL: 5WM
WKN: A1JKH7
ISIN: GB00B6YWDK49
SEDOL: B6YWDK4

~ends~

For press information, contact: 
Global Press and Public Relations: 

Gabriel Luca 
Wedgewood Communications 
60 Madison Avenue 
Suite 1212 
New York 
NY 10010 USA 
Tel: +1 646 592 7559
westhouse@wwprnews.com

Westhouse Medical Services Plc (FRA:5WM) Announces Appointment of Ms Joanne Smith as New Non-Executive Director

newsroom@abnnewswire.net — Tue, 11 Dec 2012 09:19:24 GMT

Healthcare specialist Westhouse Medical Services Plc (FRA:5WM) today announces the appointment of Ms Joanne Smith as Non-Executive Director. Joanne Smith has worked in Financial Services for over 20 years. Her expertise is in compliance related matters, across all sectors of the industry.

Since 1990 she has worked in a number of Financial Services Companies including Royal Insurance, HBOS and KPMG, as well as the Financial Services Authority.

She has an MBA from Ecole Nationale des Ponts et Chaussees in Paris.

In 2000 she founded The Consulting Consortium which specialises in providing compliance services and resources. Joanne's drive and passion has turned TCC from an initially small outfit to the award winning company it is today.

Westhouse is currently developing a number of medical devices, including BreastCheck - a new low-cost, non-invasive breast cancer screening product which can act as a precursor to mammogram scanning. BreastCheck is due for launch in 2013.

Westhouse recently acquired from US-listed Sunridge International via. Sunridge's subsidiary, Ophthalmic International Inc, a glaucoma procedure called PNT, which could revolutionise the way glaucoma is treated globally.

WESTHOUSE MEDICAL SERVICES PLC
SYMBOL: 5WM
WKN: A1JKH7
ISIN: GB00B6YWDK49
SEDOL: B6YWDK4

~ends~

For press information, contact: 
Global Press and Public Relations: 

Gabriel Luca 
Wedgewood Communications 
60 Madison Avenue 
Suite 1212 
New York 
NY 10010 USA                     
Tel: +1 646 592 7559
westhouse@wwprnews.com

Westhouse Medical Services Plc (FRA:5WM) Announces Appointment of Mr Kevin Riches as New Non-Executive Director

newsroom@abnnewswire.net — Mon, 10 Dec 2012 09:24:32 GMT

Healthcare specialist Westhouse Medical Services Plc (FRA:5WM) today announces the appointment of Mr Kevin Riches as Non-Executive Director. Kevin has over 25 years experience in start up and mature businesses, both large and small.

The sectors have ranged from IT and communications through environmental and finance to PFI in hospitals and Education.

Kevin has a proven track record as a change agent and has an excellent, mature network of business leaders, contacts and partners. Recent successful business engagements include SpinVox, Dennis Publishing, Carteme, Phones 4 U, PRS and PTS Consulting.

He is a Director and Shareholder at European American Capital, Carteme, Applied Cytometry, Plasma Europe and at Waterbridge Capital

Kevin is passionate about value creation, often at a consumer level, usually delivered via B2B relationships.

Westhouse is currently developing a number of medical devices, including BreastCheck - a new low-cost, non-invasive breast cancer screening product which can act as a precursor to mammogram scanning. BreastCheck is due for launch in 2013.

Westhouse recently acquired from US-listed Sunridge International via. Sunridge's subsidiary, Ophthalmic International Inc, a glaucoma procedure called PNT, which could revolutionise the way glaucoma is treated globally.

WESTHOUSE MEDICAL SERVICES PLC
SYMBOL: 5WM
WKN: A1JKH7
ISIN: GB00B6YWDK49
SEDOL: B6YWDK4

~ends~

For press information, contact: 
Global Press and Public Relations: 

Gabriel Luca 
Wedgewood Communications 
60 Madison Avenue 
Suite 1212 
New York 
NY 10010 USA                     
Tel: +1 646 592 7559
westhouse@wwprnews.com

Westhouse Medical Services Plc (FRA:5WM) Announces Appointment of New Non-Executive Chairman

newsroom@abnnewswire.net — Wed, 28 Nov 2012 11:31:43 GMT

Healthcare specialist Westhouse Medical Services Plc (FRA:5WM) today announces the appointment of Lord Maxwell Beaverbrook as Non-Executive Chairman.

The company's founder and current Chairman, Jack Kaye stands down as Chairman to become Deputy Chairman with Executive responsibilities.

Lord Beaverbrook, a British peer, baronet, politician and businessman, was born in 1951. He is the grandson of the 1st Baron Beaverbrook (Minister of Aircraft Production 1940-1942) and the only son of Group Captain Sir Max Aitken DSO DFC.
After completing his education at Pembroke College, Cambridge, Lord Beaverbrook worked at Express Newspapers from 1972-1978, rising to General Manager of Sunday Express. From 1978 he served as Director of the Aitken/Beaverbrook Family Office, overseeing a diversified investment fund specialising in real estate, as well as in oil and gas, and insurance. During the same time frame, he also founded VenTech Investments Inc. (Canada) where he served as Executive Chairman. Under Lord Beaverbrook's direction VenTech Group became the largest home healthcare operator in the US.

After becoming a member of the House of Lords in 1985, Lord Beaverbrook was appointed Government Whip and Junior Minister at the Department of Trade & Industry in 1986. He was appointed Treasurer of the Conservative Party by Margaret Thatcher in 1990, succeeding Lord McAlpine, following a 2 year period served as Deputy Treasurer. He stepped down after the successful 1992 election campaign.
In 1993, Lord Beaverbrook's interest in the telecom industry led to the formation of Highway One AG, a broadband, multimedia, data transport company, of which he was Chairman until 1999. The company was sold to Telefonica of Spain, in 2001.
From 2000-2007 he was Chairman of Net Integration Technologies Inc of Toronto, now part of IBM. He remains the Chairman of the Beaverbrook/Aitken Family Office, which retains active investments in the UK, Europe and the US.

Lord Beaverbrook was a Director of the British Racing Drivers Club (owners of Silverstone) from 2006-2008, and has been a Director of the British Powerboat Racing Club since 2000. He is active in various charities and is currently a Vice President of the National Association of Boys Club, and the Chairman of the Beaverbrook Foundation, of which he has been a Trustee since 1974. He was a Member of Council, Homeopathic Trust 1987 - 1992.

Lord Beaverbrook is also active in the Royal Auxiliary Air Force (RAF Reserves), where he is Honorary Inspector General in the rank of Air Vice-Marshal.

Westhouse is currently developing a number of medical devices, including BreastCheck - a new low-cost, non-invasive breast cancer screening product which can act as a precursor to mammogram scanning. BreastCheck is due for launch in 2013.

Westhouse recently acquired from US-listed Sunridge International via. Sunridge's subsidiary, Ophthalmic International Inc, a glaucoma procedure called PNT, which could revolutionise the way glaucoma is treated globally.

WESTHOUSE MEDICAL SERVICES PLC
SYMBOL: 5WM
WKN: A1JKH7
ISIN: GB00B6YWDK49
SEDOL: B6YWDK4
~ends~

For press information, contact:
Global Press and Public Relations:
Gabriel Luca
Wedgewood Communications
60 Madison Avenue
Suite 1212
New York
NY 10010 USA
Tel: +1 646 592 7559
westhouse@wwprnews.com

Targeted Acquisition Part of Westhouse Medical's (FRA:5WM) Continuing International Expansion

newsroom@abnnewswire.net — Mon, 19 Nov 2012 11:53:40 GMT

Healthcare specialist Westhouse Medical Services Plc (FRA:5WM) is pleased to announce that it has acquired 52% of the issued share capital of Quy Biosciences Limited (Quy) through private placement. The acquisition values Quy at GBP3.25m The company is currently seeking to acquire the remaining 48% of Quy's issued share capital.

Quy develop clinical products and services in the regenerative medicine field. Quy are conducting and collaborating on research into wound healing technologies which will lead to further pioneering products in the regenerative medicine field through stem cell therapy and allow the company to further develop the technology for human patients.

Jack Kaye, Westhouse Chairman said "this acquisition will further enhance Westhouse's IP portfolio and make a significant contribution to the company's world wide development whilst meeting the company's ethos of bringing technology to market for the benefit of patients globally".

Westhouse is also currently developing a number of medical devices, including BreastCheck - a new low-cost, non-invasive breast cancer screening product which can act as a precursor to mammogram scanning. BreastCheck is due for launch in 2013.

Westhouse recently acquired from US-listed Sunridge International via. Sunridge's subsidiary, Ophthalmic International Inc, a glaucoma procedure called PNT, which could revolutionise the way glaucoma is treated globally.

WESTHOUSE MEDICAL SERVICES PLC
SYMBOL: 5WM
WKN: A1JKH7
ISIN: GB00B6YWDK49
SEDOL: B6YWDK4
~ends~

Westhouse Medical Services Plc
E: info@westhousemedical.com
WWW: www.westhousemedical.com

Global Press and Public Relations:
Wedgewood Communications
60 Madison Avenue
Suite 1212
New York
NY 10010 USA
WWW: www.wedgewoodcommunications.com

Westhouse Medical Services plc (WMB5:G4) $25 Million 5 Year Bond Listing

newsroom@abnnewswire.net — Wed, 10 Oct 2012 08:21:43 GMT

The Company is pleased to announce that it has listed its $25m 5yr Bond on the Danish GXG Exchange - MTF Section with effect from today's date.

Details of the Bond are as follows:-

5yr $25,000,000 Bond 2012 -2017 with 7% annual (August) coupon.

Description: 7% BDS 01/08/17 USD 100000
SEDOL: B88MV88
ISIN: GB00B88MV889
Ticker Code: WMB5:G4

Westhouse Medical Services Plc
Jack Kaye
E: jack.kaye@westhousemedical.com
E: info@westhousemedical.com
WWW: www.westhousemedical.com

Global Press and Public Relations:
Wedgewood Communications
T: +1 646 592 7559
E: westhouse@wwprnews.com

Westhouse Medical Services Plc (FRA:5WM) Announces Funding Round

newsroom@abnnewswire.net — Wed, 19 Sept 2012 06:38:54 GMT

Healthcare specialist Westhouse Medical Services Plc (FRA:5WM) today announces that it has commenced a 5m Euro (GBP3.9m) funding round to enable it to further expand its acquisition and development programmes.

Jack Kaye, Westhouse Chairman said "this funding round will allow Westhouse to complete on a number of targeted acquisitions and ensure that the company can continue to develop and support its technology to enable it to bring products to market in a timely manner"

Westhouse is currently developing a number of medical devices, including BreastCheck - a new low-cost, non-invasive breast cancer screening product which can act as a precursor to mammogram scanning. BreastCheck is due for launch in 2013.

Westhouse recently acquired from US-listed Sunridge International via. Sunridge's subsidiary, Ophthalmic International Inc, a glaucoma procedure called PNT, which could revolutionise the way glaucoma is treated globally.

Global Press and Public Relations: 
Gabriel Luca/Michael Westhaver
Wedgewood Communications
westhouse@wwprnews.com
Tel: +1-646-592-7559

Westhouse Medical Services Plc
E: info@westhousemedical.com
WWW: www.westhousemedical.com

Westhouse Medical Services Plc (FRA:5WM) Announces Appointment of New Managing Director, Appointment Part of Company's International Corporate Expansion

newsroom@abnnewswire.net — Wed, 19 Sept 2012 06:02:27 GMT

Healthcare specialist Westhouse Medical Services Plc (FRA:5WM) today announces that announce the appointment of Mr Alex Renny as Managing Director.

Alex started his career in the late 80's with the British Army as a Lieutenant and Platoon Commander serving in the UK, Cyprus, Denmark, Italy and Turkey.

Following 3 years' service with the Military, he joined Chemical Bank with varying roles, cumulating in his appointment as VP Senior Trader - Interbank Trading and IR Derivatives. He has a background of Derivatives and Interbank trading, with positions at Midland Global markets and Dai-Ichi Kangyo Bank.

He took time out to complete an MBA at Cranfield School of Management following which he focused on a consulting role to a wide range of companies.

Alex was a senior management member of ROK Group where he has held numerous appointments within various subsidiaries, including Director of Corporate Development, Group CFO and Head of M & A and Corporate Strategy.

He brings to Westhouse an in depth understanding of financial markets and business expertise in both mergers and acquisitions and in corporate development. Alex also holds a BSc in Biochemistry.

Following on from Mr Renny's appointment, Jack Kaye moves to take up the role of Group Chairman.

Westhouse is currently developing a number of medical devices, including BreastCheck - a new low-cost, non-invasive breast cancer screening product which can act as a precursor to mammogram scanning. BreastCheck is due for launch in 2013.

Westhouse recently acquired from US-listed Sunridge International via. Sunridge's subsidiary, Ophthalmic International Inc, a glaucoma procedure called PNT, which could revolutionise the way glaucoma is treated globally.

Global Press and Public Relations: 
Gabriel Luca/Michael Westhaver
Wedgewood Communications
westhouse@wwprnews.com
Tel: +1-646-592-7559

Westhouse Medical Services Plc
E: info@westhousemedical.com
WWW: www.westhousemedical.com